News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
Bharat Biotech’s Covaxin has emerged as the first COVID-19 vaccine worldwide to be used for inoculating children as young as 2 years old with the subject expert committee (SEC) that counsels the Drugs Controller General of India (DCGI) endorsing emergency use authorisation (EUA) for the vaccine for kids in the 2-18 years age group.
Everest Organics Limited today announced the successful development of an anti-viral API ‘MOLNUPIRAVIR’ an additional COVID-19 treatment drug that is being developed at Lab Scale for the first-line treatment of COVID-19 in adults patients with mild to moderate symptoms.
The kit – which detects levels of serum CC16 in blood — is the result of a collaboration between the Mumbai team of the National Institute of Virology (NIV) and the National Institute for Occupational Health. “India has a high burden of silicosis with an estimate of 1.25 crore patients at the moment,” said Dr Shyam Sundar Nandi from the Mumbai laboratory, who is one of the scientists who developed the test.
Sikkim is declared to be the first fully vaccinated state of India, where 100 per cent of the population have received the first dose of vaccine and 74 per cent of the population has received the second dose as well.
Availability of injectable insulin formulation has been a major breakthrough in diabetes management. However, insulin needs to be kept in a refrigerator, which, otherwise after some hours becomes unfit for use due to fibrillation (some kind of ‘solidification’). Its prolonged storage even in normal refrigerator is also not good. Therefore, its thermal instability and fibrillation at non-refrigerated temperatures demands storage and maintenance of cold chain, making it expensive. Further, for diabetes patients who are staying at remote locations with no refrigerator facility or those who are travelling for long hours, the problem is more acute.
India’s Bharat Biotech will be producing part of the world’s only malaria vaccine that has been developed by Pharma major GSK, and was recently approved by WHO (World Health Organisation).
The Prime Minister said in normal days, India used to produce 900 metric tons of liquid medical oxygen a day. As the demand increased, India increased the production of medical oxygen by more than 10 times. He added that this was an unimaginable goal for any country in the world, but India has achieved it.
Biomoneta, a Bengaluru-based startup funded by Government of India and Karnataka Government has developed an air decontamination technology which promised to eliminate airborne COVID-19 virus with 99.9999% efficiency in any closed setting. The company has conducted validation studies at the Indian Institute of Science, Bengaluru, with support from The Department of Biotechnology’s Biotechnology Industry Research Assistance Council (DBT-BIRAC).
Pharmaceuticals & Medical Devices Bureau of India (PMBI), the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has completed the target of opening of 8,300 Mantri Bhartiya Jan Aushadhi Kendras (PMBJKs) for the FY 2021-22 before end of September, 2021. All the districts of the country have been covered under Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP). Effective IT-enabled logistics and supply-chain systems for ensuring real-time distribution of medicines at all outlets have also been introduced.
Capable of being injected owing to its two phases (liquid and gel) based on the incubation temperature, they explored its potential to serve as a material for minimally invasive treatment to replace complicated surgeries. Until now, no solution is available to prevent corneal scarring following an injury. They demonstrated, for the first time, that this hydrogel can be applied immediately after injury which helps to regenerate the cornea without scarring. Until now, no treatment is available other than partial donor corneal graft or corneal transplantation for scarring, which is already present in the visual acuity.
